Santen Pharmaceutical

Company

Investment-firm

Last deal

$22M
Local Amount - EUR 15M

Amount

Post-IPO Equity

Stage

26.09.2009

Date

5

all rounds

$74.3M

Total amount

General

About Company
Santen is a Japanese pharmaceutical company that specializes in developing and manufacturing ophthalmic products.

Industry

Sector :

Subsector :

Keywords :

Also Known As

santen

founded date

01.01.1890

Number of employees

Company Type

For Profit

Last funding type

Post-IPO Equity

IPO status

Private

Description

With over 120 years of experience, Santen is committed to improving the quality of life for patients worldwide by challenging unmet needs in ophthalmology through passionate research and successful collaboration. They have a global presence, with clinical development centers in Europe, Japan, and the United States, and are dedicated to protecting and improving patients' Eye Health and Vision Care. Santen remains focused on the discovery, exploration, and development of vision therapies now and in the future, as they expand to accommodate new and evolving initiatives in ophthalmic research, regulatory management, production, marketing, or distribution.
Contacts

Phone number

Social url